Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “No Evidence of Disease”

103 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 103 results

Not applicableUnknownNCT01089270
What this trial is testing

Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree Relatives

Who this might be right for
Parkinson Disease
Tel-Aviv Sourasky Medical Center 80
Early research (Phase 1)Study completedNCT00679094
What this trial is testing

Bowman-Birk Inhibitor Concentrate in Healthy Men

Who this might be right for
Healthy, no Evidence of Disease
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT00847171
What this trial is testing

Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Testing effectiveness (Phase 2)Ended earlyNCT02054104
What this trial is testing

Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum

Who this might be right for
Thoracic SarcomasThorasic CancersCancers of Non-thoracic Origin With Metastases to the Lungs or Pleura+2 more
National Cancer Institute (NCI) 21
Post-approval studies (Phase 4)Ended earlyNCT00854750
What this trial is testing

Modeling and Treating the Pathophysiology of Demyelination in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Elliot Frohman 1
Early research (Phase 1)Ended earlyNCT01336387
What this trial is testing

Dose-Finding of Retinoid 9cUAB30 in Healthy Volunteers

Who this might be right for
Healthy, no Evidence of Disease
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Study completedNCT01641874
What this trial is testing

The McKenzie System With Arthritic Knees: Do Some Knees Respond to Specific Exercise More Than General or no Exercise

Who this might be right for
Knee Osteoarthritis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 180
Early research (Phase 1)Study completedNCT00450957
What this trial is testing

Lycopene in Healthy Male Participants

Who this might be right for
Healthy, no Evidence of DiseaseProstate Cancer
National Cancer Institute (NCI) 20
Not applicableUnknownNCT05635630
What this trial is testing

Predictive Value of ctDNA for NED Status in mCRC and Its Utility in Guiding Therapeutic Intervention

Who this might be right for
Metastatic Colorectal CancerNo Evidence of Disease StatusctDNA Monitoring
Fudan University 110
Large-scale testing (Phase 3)Study completedNCT00263822
What this trial is testing

Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
European Organisation for Research and Treatment of Cancer - EORTC 835
Testing effectiveness (Phase 2)Study completedNCT00020254
What this trial is testing

Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI)
Not applicableUnknownNCT00571883
What this trial is testing

Neck Surgery in Treating Patients With Early-Stage Oral Cancer

Who this might be right for
Head and Neck Cancer
The Facial Surgery Research Foundation 652
Testing effectiveness (Phase 2)Looking for participantsNCT05360277
What this trial is testing

Maintenance Tislelizumab + Capecitabine to Treat Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer，NED
Yanhong Deng 52
Post-approval studies (Phase 4)Study completedNCT00566124
What this trial is testing

Basal Insulins - Pharmacodynamics

Who this might be right for
Diabetes
University of Aarhus 10
Early research (Phase 1)Study completedNCT00619060
What this trial is testing

Topical Myristyl Nicotinate Cream on the Skin of Healthy Volunteers

Who this might be right for
Healthy
University of Arizona 22
Early research (Phase 1)Study completedNCT00896974
What this trial is testing

Study of 9cUAB30 in Healthy Participants

Who this might be right for
No Evidence of Disease
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT02090933
What this trial is testing

Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy Volunteers

Who this might be right for
No Evidence of Disease
National Cancer Institute (NCI) 25
Not applicableWithdrawnNCT01292421
What this trial is testing

Edible Hepatitis B Vaccine Therapy in Healthy Participants Who Have Undergone Previous Vaccination

Who this might be right for
Healthy, no Evidence of Disease
Roswell Park Cancer Institute
Early research (Phase 1)Study completedNCT00784394
What this trial is testing

Diindolylmethane in Preventing Cancer in Healthy Volunteers

Who this might be right for
Healthy, no Evidence of Disease
National Cancer Institute (NCI) 20
Not applicableStudy completedNCT02725385
What this trial is testing

Stress and Coping in Caregivers of Younger Patients With Cancer

Who this might be right for
AnxietyDepression
Wake Forest University Health Sciences 163
Load More Results